Q&A with Dr Tom McColm Research Director at Zeus Capital
29th November 2016
Zeus Capital’S Dr Tom McColm discusses Ilika plc in this exclusive interview with DirectorsTalk
Zeus Capital’S Dr Tom McColm discusses Ilika plc in this exclusive interview with DirectorsTalk
European Metals’ Keith Coughlan discusses the interim upgrade to the Cinovec lithium/tin project, the progress of the feasibility study, relative value and the main reasons for investors to invest in EMH in this exclusive interview with DirectorsTalk
MTI Wireless Edge’s Moni Borovitz discusses their subsidiary Mottech Water Solutions, why it is a great acquisition and how their solutions help farmer’s achieve cost savings in this exclusive interview with DirectorsTalk
Zeus Capital’s Mike Allen discusses Cambria Automobiles PLC in this exclusive interview with DirectorsTalk
Silence Therapeutics’ Ali Mortazavi discusses in vivo CRISPR/Cas9 gene editing data in this exclusive interview with DirectorsTalk
Ceres Power Holdings’ Mark Selby discusses the latest version of their SteelCell platform, commercialisation, progress of their large OEM projects and when we can expect to see fully commercial products in the field in this exclusive interview with DirectorsTalk
OptiBiotix Health’s Stephen O’Hara discusses their recent scientific and commercial update in this exclusive interview with DirectorsTalk
Versarien’s Neill Ricketts discusses their new healthcare graphene project in this exclusive interview with DirectorsTalk
Today I have the opportunity to chat with Nicolas Serandour, the new CEO of Advanced Oncotherapy Plc (LON:AVO), a company whose aim is to manufacture new radiotherapy machines for treating
Lighthouse Group’s Malcolm Streatfield discusses their new affinity contract with Fire Brigades Union in this exclusive interview with DirectorsTalk
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
